Nu Skin Enterprises (NUS)
Nu Skin Enterprises on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as wholesale-drugs, proprietaries & druggists' sundries.
4.6M
Short interest
settlement 2026-09-30
8.5
Days to cover
-0.4 days vs prior
50.1%
Short share of volume
2026-10-09
82
Fails to deliver
settlement 2026-09-04
Thu 5 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in NUS is 4,617,694 shares, up 95,807 shares over the last month. Over the last 48 readings it ranged from 1,164,966 shares (31 December 2024) to 4,767,898 shares (15 September 2026). The latest reading sits at the top of that range. At the reported average volume of 544K shares a day that is 8.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/nus" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 4,617,694 | -3.1% | 544,394 | 8.48 |
| 2026-09-15 | 4,767,898 | +5.4% | 538,607 | 8.85 |
| 2026-08-31 | 4,521,887 | +1.8% | 483,190 | 9.36 |
| 2026-08-14 | 4,442,194 | -4.0% | 744,983 | 5.96 |
| 2026-07-31 | 4,625,814 | +10.5% | 462,459 | 10.00 |
| 2026-07-15 | 4,185,418 | +10.2% | 699,245 | 5.99 |
| 2026-06-30 | 3,797,634 | +5.2% | 1,074,457 | 3.53 |
| 2026-06-15 | 3,609,618 | +16.8% | 685,493 | 5.27 |
| 2026-05-29 | 3,089,744 | +0.2% | 688,170 | 4.49 |
| 2026-05-15 | 3,084,181 | +15.7% | 681,634 | 4.52 |
| 2026-04-30 | 2,666,934 | +7.0% | 401,451 | 6.64 |
| 2026-04-15 | 2,491,619 | +10.2% | 395,281 | 6.30 |
| 2026-03-31 | 2,260,625 | +0.1% | 563,492 | 4.01 |
| 2026-03-13 | 2,259,594 | +8.6% | 592,634 | 3.81 |
| 2026-02-27 | 2,081,641 | +2.8% | 587,076 | 3.55 |
| 2026-02-13 | 2,025,767 | +15.2% | 573,213 | 3.53 |
| 2026-01-30 | 1,758,724 | -16.0% | 582,972 | 3.02 |
| 2026-01-15 | 2,092,801 | -1.7% | 374,720 | 5.58 |
| 2025-12-31 | 2,128,269 | -7.3% | 447,116 | 4.76 |
| 2025-12-15 | 2,297,081 | -3.7% | 438,038 | 5.24 |
| 2025-11-28 | 2,386,132 | -1.6% | 444,197 | 5.37 |
| 2025-11-14 | 2,423,882 | +5.1% | 585,175 | 4.14 |
| 2025-10-31 | 2,306,342 | +6.1% | 340,823 | 6.77 |
| 2025-10-15 | 2,173,387 | -6.7% | 482,360 | 4.51 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of NUS volume is 50.1%, down 11.7 points over the last five sessions. Over the last 30 readings it ranged from 30.8% (2 September 2026) to 73.8% (9 September 2026). The latest reading is 8.1 points below the 30-session average of 58.2%, on 122K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 61K | 122K | 50.1% | 1,511 |
| 2026-10-08 | 84K | 143K | 58.5% | 0 |
| 2026-10-07 | 100K | 198K | 50.5% | 14 |
| 2026-10-06 | 78K | 146K | 53.0% | 0 |
| 2026-10-05 | 81K | 182K | 44.6% | 33 |
| 2026-10-02 | 85K | 138K | 61.8% | 110 |
| 2026-10-01 | 162K | 222K | 73.0% | 0 |
| 2026-09-30 | 117K | 167K | 69.8% | 20 |
| 2026-09-29 | 104K | 145K | 71.8% | 0 |
| 2026-09-28 | 54K | 94K | 57.5% | 0 |
| 2026-09-25 | 72K | 122K | 59.5% | 1 |
| 2026-09-24 | 106K | 162K | 65.7% | 434 |
| 2026-09-23 | 51K | 84K | 61.4% | 0 |
| 2026-09-22 | 118K | 161K | 73.1% | 321 |
| 2026-09-21 | 95K | 195K | 48.9% | 308 |
| 2026-09-18 | 107K | 193K | 55.6% | 438 |
| 2026-09-17 | 101K | 150K | 67.5% | 256 |
| 2026-09-16 | 90K | 161K | 55.7% | 184 |
| 2026-09-15 | 78K | 133K | 58.8% | 423 |
| 2026-09-14 | 108K | 191K | 56.8% | 0 |
| 2026-09-11 | 103K | 163K | 63.4% | 18 |
| 2026-09-10 | 96K | 159K | 60.3% | 0 |
| 2026-09-09 | 126K | 171K | 73.8% | 0 |
| 2026-09-08 | 80K | 133K | 60.3% | 160 |
| 2026-09-04 | 74K | 145K | 51.2% | 1 |
| 2026-09-03 | 117K | 198K | 59.0% | 101 |
| 2026-09-02 | 83K | 270K | 30.8% | 500 |
| 2026-09-01 | 146K | 269K | 54.4% | 12 |
| 2026-08-31 | 133K | 325K | 40.8% | 5,284 |
| 2026-08-28 | 79K | 135K | 58.6% | 206 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 4 September 2026, the fails-to-deliver balance in NUS is 82 shares, up 81 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (27 August 2026) to 40,227 shares (19 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-04 | 82 | $4.70 | $385 |
| 2026-08-28 | 1 | $4.79 | $5 |
| 2026-08-27 | 1 | $4.84 | $5 |
| 2026-08-25 | 8,284 | $4.77 | $40K |
| 2026-08-21 | 7,112 | $4.65 | $33K |
| 2026-08-19 | 40,227 | $4.70 | $189K |
| 2026-07-20 | 59 | $5.24 | $309 |
| 2026-07-17 | 9,786 | $5.39 | $53K |
| 2026-07-16 | 11,617 | $5.17 | $60K |
| 2026-07-06 | 1,250 | $5.01 | $6K |
| 2026-06-23 | 643 | $5.00 | $3K |
| 2026-06-16 | 1,982 | $5.15 | $10K |
| 2026-06-15 | 4,431 | $5.47 | $24K |
| 2026-06-10 | 177 | $5.44 | $963 |
| 2026-05-26 | 402 | $5.93 | $2K |
| 2026-05-21 | 687 | $5.84 | $4K |
| 2026-05-13 | 13,592 | $6.55 | $89K |
| 2026-05-05 | 481 | $7.05 | $3K |
| 2026-04-22 | 9,639 | $7.47 | $72K |
| 2026-04-02 | 890 | $7.36 | $7K |
| 2026-04-01 | 288 | $7.28 | $2K |
| 2026-03-31 | 509 | $7.16 | $4K |
| 2026-03-13 | 194 | $7.11 | $1K |
| 2026-03-03 | 99 | $8.08 | $800 |
| 2026-01-22 | 5 | $11.10 | $56 |
| 2026-01-21 | 384 | $11.06 | $4K |
| 2026-01-16 | 100 | $11.34 | $1K |
| 2026-01-14 | 99 | $10.63 | $1K |
| 2025-12-29 | 34 | $9.84 | $335 |
| 2025-11-14 | 1,167 | $9.78 | $11K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONNo open-market insider trades were reported for NUS in the last 90 days. The most recent filings are listed below. Latest filing: WOODBURY EDWINA D (Director) on 2026-09-09.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-09 | WOODBURY EDWINA D | Director | Grant | 22 | $4.85 | $107 | 62K |
| 2026-06-10 | WOODBURY EDWINA D | Director | Grant | 19 | $5.43 | $103 | 62K |
| 2026-06-02 | Winett James M | Director | Sell | 7K | $5.62 | $40K | 37K |
| 2026-06-01 | Winett James M | Director | Grant | 27K | $0.00 | $0 | 45K |
| 2026-06-01 | Nathanson Laura | Director | Grant | 27K | $0.00 | $0 | 57K |
| 2026-06-01 | Zorko Mark A | Director | Grant | 27K | $0.00 | $0 | 61K |
| 2026-06-01 | WOODBURY EDWINA D | Director | Sell | 7K | $5.70 | $41K | 62K |
| 2026-06-01 | WOODBURY EDWINA D | Director | Grant | 27K | $0.00 | $0 | 70K |
| 2026-06-01 | Thomas Pisano R. | Director | Grant | 27K | $0.00 | $0 | 117K |
| 2026-06-01 | CAMPBELL DANIEL W | Director | Grant | 27K | $0.00 | $0 | 66K |
| 2026-06-01 | Battle Emma S. | Director | Grant | 27K | $0.00 | $0 | 58K |
| 2026-05-11 | Nathanson Laura | Director | Sell | 3K | $6.73 | $18K | 30K |
| 2026-03-11 | WOODBURY EDWINA D | Director | Grant | 14 | $7.31 | $102 | 43K |
| 2026-03-06 | Thomas James D | Chief Financial Officer | Grant | 115K | $0.00 | $0 | 267K |
| 2026-03-06 | NAPIERSKI RYAN S | President and CEO | Grant | 282K | $0.00 | $0 | 1.0M |
| 2026-03-06 | Keisel Justin S | EVP, President of Global Sales | Grant | 47K | $0.00 | $0 | 160K |
| 2026-03-06 | Hatchett Steven Keith | Chief Product Officer | Grant | 78K | $0.00 | $0 | 261K |
| 2026-03-06 | Clark Chayce David | EVP, COO and CLO | Grant | 139K | $0.00 | $0 | 391K |
| 2026-02-26 | Thomas James D | Chief Financial Officer | Tax withholding | 29K | $8.63 | $247K | 152K |
| 2026-02-26 | NAPIERSKI RYAN S | President and CEO | Tax withholding | 125K | $8.63 | $1.1M | 720K |
| 2026-02-26 | Keisel Justin S | EVP, President of Global Sales | Tax withholding | 14K | $8.63 | $118K | 113K |
| 2026-02-26 | Hatchett Steven Keith | Chief Product Officer | Tax withholding | 26K | $8.63 | $224K | 183K |
| 2026-02-26 | Clark Chayce David | EVP and General Counsel | Tax withholding | 46K | $8.63 | $393K | 252K |
| 2026-02-15 | Thomas James D | Chief Financial Officer | Tax withholding | 12K | $8.36 | $98K | 181K |
| 2026-02-15 | NAPIERSKI RYAN S | President and CEO | Tax withholding | 49K | $8.36 | $410K | 844K |
| 2026-02-15 | Keisel Justin S | EVP, President of Global Sales | Tax withholding | 2K | $8.36 | $13K | 127K |
| 2026-02-15 | Hatchett Steven Keith | Chief Product Officer | Tax withholding | 11K | $8.36 | $90K | 209K |
| 2026-02-15 | Clark Chayce David | EVP and General Counsel | Tax withholding | 18K | $8.36 | $150K | 297K |
| 2026-02-10 | Thomas James D | Chief Financial Officer | Grant | 47K | $0.00 | $0 | 193K |
| 2026-02-10 | Thomas James D | Chief Financial Officer | Grant | 10K | $0.00 | $0 | 145K |
| 2026-02-10 | NAPIERSKI RYAN S | President and CEO | Grant | 207K | $0.00 | $0 | 893K |
| 2026-02-10 | NAPIERSKI RYAN S | President and CEO | Grant | 43K | $0.00 | $0 | 686K |
| 2026-02-10 | Keisel Justin S | EVP, President of Global Sales | Grant | 35K | $0.00 | $0 | 128K |
| 2026-02-10 | Keisel Justin S | EVP, President of Global Sales | Grant | 3K | $0.00 | $0 | 94K |
| 2026-02-10 | Hatchett Steven Keith | Chief Product Officer | Grant | 43K | $0.00 | $0 | 220K |
| 2026-02-10 | Hatchett Steven Keith | Chief Product Officer | Grant | 9K | $0.00 | $0 | 177K |
| 2026-02-10 | Clark Chayce David | EVP and General Counsel | Grant | 75K | $0.00 | $0 | 315K |
| 2026-02-10 | Clark Chayce David | EVP and General Counsel | Grant | 16K | $0.00 | $0 | 240K |
| 2025-12-20 | Clark Chayce David | EVP and General Counsel | Tax withholding | 9K | $10.27 | $93K | 224K |
| 2025-12-10 | WOODBURY EDWINA D | Director | Grant | 10 | $10.35 | $104 | 43K |
| 2025-11-11 | Hatchett Steven Keith | Chief Product Officer | Buy | 6K | $9.61 | $53K | 168K |
| 2025-09-10 | WOODBURY EDWINA D | Director | Grant | 9 | $11.52 | $104 | 43K |
| 2025-09-04 | Nathanson Laura | Director | Sell | 6K | $12.22 | $79K | 33K |
| 2025-09-03 | Clark Chayce David | EVP and General Counsel | Sell | 20K | $11.97 | $239K | 233K |
| 2025-08-29 | CAMPBELL DANIEL W | Director | Sell | 23K | $12.10 | $283K | 53K |
| 2025-08-29 | CAMPBELL DANIEL W | Director | Sell | 9K | $12.12 | $110K | 39K |
| 2025-08-01 | Thomas James D | Chief Financial Officer | Tax withholding | 915 | $8.20 | $8K | 135K |
| 2025-08-01 | Clark Chayce David | EVP and General Counsel | Tax withholding | 205 | $8.20 | $2K | 253K |
| 2025-06-11 | WOODBURY EDWINA D | Director | Grant | 13 | $8.09 | $105 | 43K |
| 2025-06-02 | Battle Emma S. | Director | Grant | 18K | $0.00 | $0 | 36K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON3 Form 144 notices on file for NUS worth $101K at the prices reported; 0 in the last 90 days worth $0. Latest: Winett James M filed on 2026-06-02 to sell 7,203 shares ($40K) from 2026-06-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-06-02 | Winett James MDirector | 7K | $40K | 0.015% | 2026-06-02 | Fidelity Brokerage Services LLC |
| 2026-06-01 | WOODBURY EDWINA DDirector | 7K | $41K | 0.015% | 2026-06-01 | Fidelity Brokerage Services LLC |
| 2026-05-11 | Nathanson LauraDirector | 3K | $19K | 0.005% | 2026-05-11 | William Blair and Company LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of NUS in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-14 | 13G/Ano. 1 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCinvestment adviser | 0 | 4.5% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 17 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding NUS at their latest 13F. JSON5 of the 30 tracked managers held NUS at their latest 13F, $24.1M in total at quarter-end prices. Renaissance Technologies is the largest at $8.5M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 1.6M | $8.5M | 0.01% | -93K |
| Two Sigma Investments | 2026-06-30 | 1.2M | $6.2M | 0.00% | +157K |
| AQR Capital Management | 2026-06-30 | 789K | $4.0M | 0.00% | -447K |
| Citadel Advisors | 2026-06-30 | 655K | $3.5M | 0.00% | +427K |
| D. E. Shaw & Co. | 2026-06-30 | 381K | $2.0M | 0.00% | -63K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Nu Skin Enterprises reported revenue of $320.1M, down 17.1% from the same quarter a year earlier, and net loss of $249.8M (-5.14 diluted EPS). In FY 2025 it generated $80.3M of operating cash flow and spent $20.0M on buybacks and $11.8M on dividends. As of 2026-06-30, cash was $189.6M against $193.7M of debt.
- Cash
- $189.6M
- Debt
- $193.7M
- Equity
- $542.7M
- Total assets
- $1.12B
- Shares outstanding
- 48,676,634
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $320.1M | -$249.8M | -78.0% | -5.14 |
| Q1 FY 2026 | 2026-03-31 | $320.6M | $1.8M | 0.6% | 0.04 |
| Q4 FY 2025derived | 2025-12-31 | $370.3M | $14.5M | 3.9% | n/a |
| Q3 FY 2025 | 2025-09-30 | $364.2M | $17.1M | 4.7% | 0.34 |
| Q2 FY 2025 | 2025-06-30 | $386.1M | $21.1M | 5.5% | 0.43 |
| Q1 FY 2025 | 2025-03-31 | $364.5M | $107.5M | 29.5% | 2.14 |
| Q4 FY 2024derived | 2024-12-31 | $445.6M | -$36.1M | -8.1% | n/a |
| Q3 FY 2024 | 2024-09-30 | $430.1M | $8.3M | 1.9% | 0.17 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.49B | $160.2M | $80.3M | $34.3M | $20.0M | $11.8M |
| FY 2024 | 2024-12-31 | $1.73B | -$146.6M | $111.7M | $41.6M | $0 | $11.9M |
| FY 2023 | 2023-12-31 | $1.97B | $8.6M | $118.6M | $58.5M | $13.0M | $77.6M |
| FY 2022 | 2022-12-31 | $2.23B | $104.8M | $108.1M | $59.1M | $70.0M | $77.0M |
| FY 2021 | 2021-12-31 | $2.70B | $147.3M | $141.6M | $68.6M | $80.4M | $76.3M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Nu Skin Enterprises in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Nu Skin Enterprises (NUS), SEC CIK 1021561, listed on NYSE, classified by the SEC as wholesale-drugs, proprietaries & druggists' sundries. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-04.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-06-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-07.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-09.JSON and CSV
- Company record
- EDGAR filing index for CIK 1021561Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as wholesale-drugs, proprietaries & druggists' sundries
Other company pages
- MUMicron Technology
- NVDANVIDIA
- METAMeta Platforms
- SNDKSandisk
- SPCXSpaceX
- TSLATesla
- AAPLApple
- AMDAdvanced Micro Devices
- INTCIntel
- MSFTMicrosoft
- AMZNAmazon.com
- GOOGLAlphabet
- AVGOBroadcom
- GOOGAlphabet
- BEBloom Energy
- ORCLOracle
- DELLDell Technologies
- LITELumentum Holdings
- TSMTaiwan Semiconductor Manufacturing
- MRVLMarvell Technology
Datasets
Frequently Asked Questions
How much of NUS is sold short?
What is NUS's daily short volume?
Does NUS have fails to deliver?
Are NUS insiders buying or selling?
Have NUS insiders filed to sell?
Who owns 5% or more of NUS?
What did NUS report last quarter?
Which tracked 13F managers own NUS?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.